Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment.
Ochs
Hans D
HD
Department of Pediatrics, University of Washington School of Medicine, Children's Hospital and Regional Medical Center, Seattle Children's Hospital Research Institute, Seattle, Washington 98101, USA. allgau@u.washington.edu
D019013:CD40 Antigens / Q000172:deficiency / Q000235:genetics; D023201:CD40 Ligand / Q000172:deficiency / Q000235:genetics; D004406:Dysgammaglobulinemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D053358:Ectodermal Dysplasia 1, Anhidrotic / Q000150:complications / Q000235:genetics; D006801:Humans; D053306:Hyper-IgM Immunodeficiency Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D053307:Hyper-IgM Immunodeficiency Syndrome, Type 1 / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006942:Hypergammaglobulinemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007075:Immunoglobulin M / Q000096:biosynthesis / Q000097:blood* / Q000172:deficiency; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*
D019013:CD40 Antigens; D007075:Immunoglobulin M; D023201:CD40 Ligand